Yang Meng

3.3k total citations · 1 hit paper
72 papers, 2.6k citations indexed

About

Yang Meng is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Yang Meng has authored 72 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 16 papers in Cancer Research and 10 papers in Genetics. Recurrent topics in Yang Meng's work include MicroRNA in disease regulation (10 papers), RNA modifications and cancer (8 papers) and Cell death mechanisms and regulation (7 papers). Yang Meng is often cited by papers focused on MicroRNA in disease regulation (10 papers), RNA modifications and cancer (8 papers) and Cell death mechanisms and regulation (7 papers). Yang Meng collaborates with scholars based in China, United States and Iran. Yang Meng's co-authors include Liang Xu, Jeffrey DeSano, Theodore S. Lawrence, Qing Ji, Min Zhang, Daiming Fan, Xinbao Hao, Wenhua Tang, Yao Dai and Eric R. Fearon and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Yang Meng

64 papers receiving 2.6k citations

Hit Papers

MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-In... 2009 2026 2014 2020 2009 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Meng China 22 1.9k 1.2k 532 231 174 72 2.6k
Guihua Wang China 29 1.5k 0.8× 678 0.6× 415 0.8× 243 1.1× 412 2.4× 88 2.5k
Zhuo Cheng China 25 1.0k 0.5× 520 0.4× 287 0.5× 232 1.0× 225 1.3× 73 1.9k
Li‐Wha Wu Taiwan 30 1.8k 1.0× 556 0.5× 757 1.4× 193 0.8× 649 3.7× 77 3.2k
Rui Zhou China 25 1.8k 0.9× 1.4k 1.2× 485 0.9× 129 0.6× 390 2.2× 86 2.8k
Xiaodong Zhao China 27 1.7k 0.9× 531 0.5× 370 0.7× 136 0.6× 209 1.2× 142 2.9k
Ziliang Wang China 32 1.4k 0.7× 782 0.7× 596 1.1× 245 1.1× 327 1.9× 102 2.6k
Tao Peng China 28 1.8k 1.0× 833 0.7× 368 0.7× 128 0.6× 213 1.2× 104 2.8k
Xiaoping Zhang China 35 1.9k 1.0× 1.5k 1.3× 245 0.5× 234 1.0× 326 1.9× 79 2.9k

Countries citing papers authored by Yang Meng

Since Specialization
Citations

This map shows the geographic impact of Yang Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Meng more than expected).

Fields of papers citing papers by Yang Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Meng. The network helps show where Yang Meng may publish in the future.

Co-authorship network of co-authors of Yang Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Meng. A scholar is included among the top collaborators of Yang Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Meng. Yang Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuanyang, Feng Lin, Gang Yang, et al.. (2025). RNA binding protein DDX3X drives pancreatic cancer progression via the TLE2-MYL9 axis. Science Advances. 11(37). eadw9519–eadw9519.
2.
Liu, Sicheng, Yang Zhang, Yang Meng, et al.. (2025). Multi-omics analyses identify mannose phosphate isomerase-centered hypoxia-induced angiogenesis signature in colorectal cancer. Journal of Translational Medicine. 23(1). 1246–1246.
3.
Cui, Kaiyu, John H. Zhang, Wei He, et al.. (2025). Effects of 8-Week High-Intensity Interval Training Intervention Regulating the SIRT1/PGC1α Pathway on Hippocampal Neuron Injury and Cognitive Impairment in Obese Rats. Current Developments in Nutrition. 9(10). 107548–107548.
4.
Meng, Yang, et al.. (2025). The burden and temporal trend of early onset pancreatic cancer based on the GBD 2021. npj Precision Oncology. 9(1). 32–32. 2 indexed citations
5.
Liu, Sicheng, Yang Meng, Yaguang Zhang, et al.. (2024). Integrative analysis of senescence-related genes identifies robust prognostic clusters with distinct features in hepatocellular carcinoma. Journal of Advanced Research. 69. 107–123. 11 indexed citations
6.
Wang, Xinru, Yang Meng, Duolu Li, et al.. (2024). Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells. Frontiers in Pharmacology. 15. 1303732–1303732. 7 indexed citations
7.
Shi, Yingchao, Hao Dong, Yang Meng, et al.. (2024). Decoding the spatiotemporal regulation of transcription factors during human spinal cord development. Cell Research. 34(3). 193–213. 10 indexed citations
8.
Zhang, Tianyu, et al.. (2022). Role of biologics in refractory recurrent aphthous stomatitis. Journal of Oral Pathology and Medicine. 51(8). 694–701. 10 indexed citations
9.
Zhou, Chuang, Xiaofeng Zheng, Yanni Zhang, et al.. (2022). The draft genome of the Tibetan partridge (Perdix hodgsoniae) provides insights into its phylogenetic position and high-altitude adaptation. Journal of Heredity. 114(2). 175–188. 4 indexed citations
10.
Liu, Sicheng, Yaguang Zhang, Lei Qiu, et al.. (2022). Uncovering N4-Acetylcytidine-Related mRNA Modification Pattern and Landscape of Stemness and Immunity in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology. 10. 861000–861000. 20 indexed citations
11.
Chen, Xiang, Yang Meng, Mengjia Tang, et al.. (2020). A paternally inherited non‐sense variant c.424G>T (p.G142*) in the first exon of XLαs in an adult patient with hypophosphatemia and osteopetrosis. Clinical Genetics. 97(5). 712–722. 5 indexed citations
12.
Zhou, Chuang, Yi Liu, Lu Qiao, et al.. (2020). Genome-Wide Analyses Provide Insights into the Scavenging Lifestyle of the Striped Hyena ( Hyaena hyaena ). DNA and Cell Biology. 39(10). 1872–1885. 3 indexed citations
13.
Meng, Yang, et al.. (2019). Novel naphthalene-enoates: Design and anticancer activity through regulation cell autophagy. Biomedicine & Pharmacotherapy. 113. 108747–108747. 6 indexed citations
14.
Hu, Xiao, Yang Meng, Lian Xu, et al.. (2019). Cul4 E3 ubiquitin ligase regulates ovarian cancer drug resistance by targeting the antiapoptotic protein BIRC3. Cell Death and Disease. 10(2). 104–104. 40 indexed citations
15.
Sun, Lina, Zheng Zhi, Liangyan Chen, et al.. (2017). SIRT1 suppresses colorectal cancer metastasis by transcriptional repression of miR-15b-5p. Cancer Letters. 409. 104–115. 73 indexed citations
16.
Yang, Huaxia, P Liu, Junhua Zhang, et al.. (2015). Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b. Oncogene. 35(28). 3647–3657. 119 indexed citations
17.
Meng, Yang, Shengnan Li, Long‐Xin Gui, et al.. (2013). Double-negative feedback loop between Wnt/β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma. Journal of Cell Science. 126(Pt 24). 5692–703. 58 indexed citations
18.
Cai, Wangyu, Qicong Luo, Qiu-Wan Wu, et al.. (2013). Wnt/β-catenin pathway represses let-7 microRNAs expression via transactivation of Lin28 to augment breast cancer stem cell expansion. Journal of Cell Science. 126(Pt 13). 2877–89. 111 indexed citations
19.
Meng, Yang. (2011). Effect of angelica keiskei koidz chalcone on PCNA and BCL-2 protein expression of mice hepatocarcinoma cells. Journal of Toxicology.
20.
Meng, Yang, Wenhua Tang, Yao Dai, et al.. (2008). Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa. Molecular Cancer Therapeutics. 7(7). 2192–2202. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026